Ọmụmụ Ihe Ndị Dị Ugbu A
01 lee nkọwa zuru ezu
Ịlụso ọrịa kansa hepatocellular ọgụ site na iji Bioocus GPC3 CAR-T Therapy
2025-11-26
Aha: Pawan
Okike:Nwoke
Afọ: 67
Mba:Ndị India
Nchọpụta: Ọrịa kansa hepatocellular
02 lee nkọwa zuru ezu
Mmeri Madhavan: Imeri Glioma Ụbụrụ site na iji Bioocus B7H3 CAR-T Therapy
2025-11-26
Aha: Madhavan
Okike: Nwoke
Afọ: 58
Mba: Ndị India
Nchọpụta: Glioma
03 lee nkọwa zuru ezu
Otu nwoke siri ike si India na-alụso ọrịa kansa afọ ọgụ
2025-10-30
Aha: Thirandas Shiva Prasad
Okike:Nwoke
Afọ: 32
Mba: Ndị India
Nchọpụta: Ọrịa Kansa Afọ
04 lee nkọwa zuru ezu
Melanomas nke na-eme ka mmadụ nwee nsogbu -04
2024-07-17
Onye Ọrịa:Maazị Li
Okike: Nwoke
Afọ: 45
Mba: Norwegian
Nchọpụta ọrịaMetastasis melanoma
05 lee nkọwa zuru ezu
Ọrịa kansa ovaria-03
2024-07-17
Onye Ọrịa: Oriakụ K
Okike: Nwanyị
Afọ: 55
Mba: Norwegian
Nchọpụta ọrịa: Ọrịa kansa ovarian
06 lee nkọwa zuru ezu
Mkpụkpọ anya (na mbụ), nke na-esochi etuto imeju nke metastatic-02
2024-07-17
Onye Ọrịa: Oriakụ Y
Okike: Nwanyị
Afọ: 40
Mba: Ndị Chaịna
Nchọpụta ọrịa: melanoma anya (na mbụ), nke na-esochi etuto imeju nke metastatic
07 lee nkọwa zuru ezu
Ọrịa kansa eriri afọ nke ọkwa nke anọ dị elu-01
2024-07-17
Onye ọrịa:Amaghị aha
Okike: Nwoke
Afọ: Afọ iri anọ na ise
Mba: Ndị Chaịna
Nchọpụta: Ọrịa kansa eriri afọ nke dị elu nke IV